Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03355976
Title BrUOG 354 Nivolumab +/- Ipilimumab for Ovarian and Extra-renal Clear Cell Carcinomas
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Don Dizon

fallopian tube clear cell adenocarcinoma

ovarian clear cell carcinoma

renal pelvis carcinoma

peritoneal carcinoma


Ipilimumab + Nivolumab


Age Groups: senior | adult
Covered Countries USA

No variant requirements are available.